scholarly journals Human Milk Feeding in Preterm Infants: What Has Been Done and What Is to Be Done

Nutrients ◽  
2019 ◽  
Vol 12 (1) ◽  
pp. 44 ◽  
Author(s):  
Elvira Verduci ◽  
Maria Lorella Giannì ◽  
Alessia Di Benedetto

Human milk is recommended as the natural feeding for both term and preterm infants for the several health benefits associated with its consumption [...]

Author(s):  
Elizabeth R. Schinkel ◽  
Elizabeth R. Nelson ◽  
Bridget E. Young ◽  
Robin M. Bernstein ◽  
Sarah N. Taylor ◽  
...  

Author(s):  
Jinglan Huang ◽  
Li Zhang ◽  
Jun Tang ◽  
Jing Shi ◽  
Yi Qu ◽  
...  

ObjectiveTo summarise current evidence evaluating the effects of human milk on the risk of bronchopulmonary dysplasia (BPD) in preterm infants.DesignWe searched for studies on human milk and BPD in English and Chinese databases on 26 July 2017. Furthermore, the references of included studies were also screened. The inclusion criteria in this meta-analysis were the following: (1) preterm infants (<37 weeks); (2) human milk; (3) comparing with formula feeding; (4) the outcome included BPD; and (5) the type of study was randomised controlled trial (RCT) or cohort study.ResultA total of 17 cohort studies and 5 RCTs involving 8661 preterm infants met our inclusion criteria. The ORs and 95% CIs of six groups were as follows: 0.78 (0.68 to 0.88) for exclusive human milk versus exclusive formula group, 0.77 (0.68 to 0.87) for exclusive human milk versus mainly formula group, 0.76 (0.68 to 0.87) for exclusive human milk versus any formula group, 0.78 (0.68 to 0.88) for mainly human milk versus exclusive formula group, 0.83 (0.69 to 0.99) for mainly human milk versus mainly formula group and 0.82 (0.73 to 0.93) for any human milk versus exclusive formula group. Notably, subgroup of RCT alone showed a trend towards protective effect of human milk on BPD but no statistical significance.ConclusionBoth exclusive human milk feeding and partial human milk feeding appear to be associated with lower risk of BPD in preterm infants. The quality of evidence is low. Therefore, more RCTs of this topic are needed.


2020 ◽  
Vol 36 (2) ◽  
pp. 283-290 ◽  
Author(s):  
Wenjing Peng ◽  
Siyuan Jiang ◽  
Shujuan Li ◽  
Shiwen Xia ◽  
Shushu Chen ◽  
...  

Background Previous low human milk feeding rates in Chinese neonatal intensive care units of preterm infants were reported. There are no nationwide data on these. Research Aims To investigate the current status of human milk feeding for preterm infants in Chinese units and provide baseline data for future research. Methods A secondary data analysis was conducted from a previously established clinical database including 25 Chinese neonatal intensive care units. All infants born <34 weeks gestation and admitted to participating units from May 2015 to April 2018 were enrolled. Variables analyzed were infant data collected and the human milk feeding practices at participating units were surveyed. Results A total of 24,113 infants were included. The overall and exclusive human milk feeding rates were 58.2% and 18.8%, respectively, which increased significantly during study years. We found that rates of human milk feeding decreased with increase in gestational age and birth weight. There was significant variation in human milk feeding rates among units. Most participating Chinese neonatal intensive care units have taken measures to improve the rates of human milk feeding. Conclusions The human milk feeding rates in Chinese neonatal intensive care units have continued to increase in the past 3 years, but there was significant variation among them. More efforts are needed to further increase the human milk feeding rates in China. Trial registration This study was registered NCT02600195 with clinicaltrials.gov on November 9, 2015.


2017 ◽  
Vol 44 (1) ◽  
pp. 1-22 ◽  
Author(s):  
Paula P. Meier ◽  
Tricia J. Johnson ◽  
Aloka L. Patel ◽  
Beverly Rossman

2015 ◽  
Vol 10 (7) ◽  
pp. 366-370 ◽  
Author(s):  
Hadar Moran-Lev ◽  
Francis B. Mimouni ◽  
Amit Ovental ◽  
Laurence Mangel ◽  
Dror Mandel ◽  
...  

Nutrients ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 1155 ◽  
Author(s):  
Jacopo Cerasani ◽  
Federica Ceroni ◽  
Valentina De Cosmi ◽  
Alessandra Mazzocchi ◽  
Daniela Morniroli ◽  
...  

Preterm infants may show a higher risk of adverse health outcomes, such as the development of metabolic syndrome and cognitive impairment. The most recent evidence highlights that nutrition, body composition development, and early postnatal growth may play a role in the programming of these processes. Human milk feeding has been recommended as the natural feeding for preterm infants and as a cost-effective strategy for reducing disease and economic burden. Considering that the postnatal growth retardation and aberrant body composition shown by preterm infants at the time of hospital discharge still remain important issues, we performed a literature review, aiming to provide an update about the effect of human milk feeding on these processes. On the basis of our findings, human milk feeding in preterm infants, although related to a slower weight gain than formula feeding, is associated with a better recovery of body composition through the promotion of fat-free mass deposition, which may ultimately lead to better metabolic and neurodevelopmental outcomes. Promotion and support of human milk feeding should be considered a priority in preterm infants’ care.


2020 ◽  
Vol 26 (6) ◽  
pp. 335-339
Author(s):  
Dinesh Pawale ◽  
Srinivas Murki ◽  
Dattatray Kulkarni ◽  
Avinash Kumar ◽  
Venakateshwarlu Vardhelli ◽  
...  

2004 ◽  
Vol 93 (6) ◽  
pp. 775-778 ◽  
Author(s):  
S Friedman ◽  
O Flidel-Rimon ◽  
E Lavie ◽  
ES Shinwell

Nutrients ◽  
2018 ◽  
Vol 10 (10) ◽  
pp. 1461 ◽  
Author(s):  
Stine Bering

This review focuses on the evidence for health benefits of human milk oligosaccharides (HMOs) for preterm infants to stimulate gut adaptation and reduce the incidence of necrotizing enterocolitis (NEC) in early life. The health benefits of breastfeeding are partly explained by the abundant HMOs that serve as prebiotics and immunomodulators. Gut immaturity in preterm infants leads to difficulties in tolerating enteral feeding and bacterial colonization and a high sensitivity to NEC, particularly when breast milk is insufficient. Due to the immaturity of the preterm infants, their response to HMOs could be different from that in term infants. The concentration of HMOs in human milk is highly variable and there is no evidence to support a specifically adapted high concentration in preterm milk. Further, the gut microbiota is not only different but also highly variable after preterm birth. Studies in pigs as models for preterm infants indicate that HMO supplementation to formula does not mature the gut or prevent NEC during the first weeks after preterm birth and the effects may depend on a certain stage of gut maturity. Supplemented HMOs may become more important for gut protection in the preterm infants when the gut has reached a more mature phase.


Sign in / Sign up

Export Citation Format

Share Document